Jiang R - Search Results

1

Synthesis, biological evaluation, X-ray structure, and pharmacokinetics of aminopyrimidine c-jun-N-terminal kinase (JNK) inhibitors.

Kamenecka T, Jiang R, Song X, Duckett D, Chen W, Ling YY, Habel J, Laughlin JD, Chambers J, Figuera-Losada M, Cameron MD, Lin L, Ruiz CH, LoGrasso PV. Kamenecka T, et al. Among authors: jiang r. J Med Chem. 2010 Jan 14;53(1):419-31. doi: 10.1021/jm901351f. J Med Chem. 2010. PMID: 19947601 Free PMC article.

2

3,5-Disubstituted quinolines as novel c-Jun N-terminal kinase inhibitors.

Jiang R, Duckett D, Chen W, Habel J, Ling YY, LoGrasso P, Kamenecka TM. Jiang R, et al. Bioorg Med Chem Lett. 2007 Nov 15;17(22):6378-82. doi: 10.1016/j.bmcl.2007.08.054. Epub 2007 Aug 26. Bioorg Med Chem Lett. 2007. PMID: 17911023

3

Structure-activity relationships and X-ray structures describing the selectivity of aminopyrazole inhibitors for c-Jun N-terminal kinase 3 (JNK3) over p38.

Kamenecka T, Habel J, Duckett D, Chen W, Ling YY, Frackowiak B, Jiang R, Shin Y, Song X, LoGrasso P. Kamenecka T, et al. Among authors: jiang r. J Biol Chem. 2009 May 8;284(19):12853-61. doi: 10.1074/jbc.M809430200. Epub 2009 Mar 4. J Biol Chem. 2009. PMID: 19261605 Free PMC article.

4

Synthesis and SAR of novel quinazolines as potent and brain-penetrant c-jun N-terminal kinase (JNK) inhibitors.

He Y, Kamenecka TM, Shin Y, Song X, Jiang R, Noel R, Duckett D, Chen W, Ling YY, Cameron MD, Lin L, Khan S, Koenig M, LoGrasso PV. He Y, et al. Among authors: jiang r. Bioorg Med Chem Lett. 2011 Mar 15;21(6):1719-23. doi: 10.1016/j.bmcl.2011.01.079. Epub 2011 Jan 22. Bioorg Med Chem Lett. 2011. PMID: 21316221 Free PMC article.

5

Disubstituted piperidines as potent orexin (hypocretin) receptor antagonists.

Jiang R, Song X, Bali P, Smith A, Bayona CR, Lin L, Cameron MD, McDonald PH, Kenny PJ, Kamenecka TM. Jiang R, et al. Bioorg Med Chem Lett. 2012 Jun 15;22(12):3890-4. doi: 10.1016/j.bmcl.2012.04.122. Epub 2012 May 4. Bioorg Med Chem Lett. 2012. PMID: 22617492 Free PMC article.

6

Design and synthesis of 1-aryl-5-anilinoindazoles as c-Jun N-terminal kinase inhibitors.

Jiang R, Frackowiak B, Shin Y, Song X, Chen W, Lin L, Cameron MD, Duckett DR, Kamenecka TM. Jiang R, et al. Bioorg Med Chem Lett. 2013 May 1;23(9):2683-7. doi: 10.1016/j.bmcl.2013.02.082. Epub 2013 Feb 27. Bioorg Med Chem Lett. 2013. PMID: 23518277

7

Efficient methodology for the synthesis of 3-amino-1,2,4-triazoles.

Noël R, Song X, Jiang R, Chalmers MJ, Griffin PR, Kamenecka TM. Noël R, et al. Among authors: jiang r. J Org Chem. 2009 Oct 2;74(19):7595-7. doi: 10.1021/jo9016502. J Org Chem. 2009. PMID: 19731897 Free PMC article.

8

Novel syntheses of chiral beta- and gamma-amino acid derivatives utilizing N-protected (aminoacyl)benzotriazoles from aspartic and glutamic acids.

Katritzky AR, Tao H, Jiang R, Suzuki K, Kirichenko K. Katritzky AR, et al. Among authors: jiang r. J Org Chem. 2007 Jan 19;72(2):407-14. doi: 10.1021/jo061667s. J Org Chem. 2007. PMID: 17221955

9

N-Tfa- and N-Fmoc-(alpha-aminoacyl)benzotriazoles as chiral C-acylating reagents under Friedel-Crafts reaction conditions.

Katritzky AR, Jiang R, Suzuki K. Katritzky AR, et al. Among authors: jiang r. J Org Chem. 2005 Jun 24;70(13):4993-5000. doi: 10.1021/jo050226q. J Org Chem. 2005. PMID: 15960497

10

Application of Mendelian randomized research method in oncology research: bibliometric analysis.

Chen J, Wang Y, Jiang R, Qu Y, Li Y, Zhang Y. Chen J, et al. Among authors: jiang r. Front Oncol. 2024 Dec 17;14:1424812. doi: 10.3389/fonc.2024.1424812. eCollection 2024. Front Oncol. 2024. PMID: 39741977 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,839 results

Search Page

Filters